← Back to Search

Behavioral Intervention

Digital Mental Health Intervention (DMHI) for Depression and Anxiety

N/A
Recruiting
Led By David C Mohr, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial involves older adults using Amazon Alexa to test a new voice-assisted program for managing mental health. They will receive support for goal setting, reminders, and other services. Participants will complete surveys and

Who is the study for?
This trial is for English-speaking adults aged 65 or older with depression (PHQ-9 score ≥10), who are cognitively sound (MOCA score ≥24), homebound, and have Wi-Fi. It also includes their caregivers who are over 18 and provide at least two hours of weekly support. Participants must be able to consent.Check my eligibility
What is being tested?
The study tests a voice-assisted program using Amazon Alexa aimed at managing mental health in older adults. Over 16 weeks, participants will use the program with or without a guidebook and complete surveys about their experience.See study design
What are the potential side effects?
There may not be traditional medical side effects; however, users might experience frustration or anxiety if they struggle with technology. The emotional impact of engaging with the device could vary.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety symptoms
Depressive symptoms
Secondary outcome measures
Adherence

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Mental Health Intervention (DMHI)Experimental Treatment1 Intervention
Participants randomized to Arm 1 will be sent an Amazon Alexa device, with a newly designed VIPA treatment program installed, and will receive a guidebook to help the older adult and their caregiver understand the device and utilize the VIPA treatment program to its fullest potential.
Group II: Control Treatment (CT)Active Control1 Intervention
Participants randomized to Arm 2 will be sent an Amazon Alexa device with guidebook to help the older adult and their caregiver understand how to use the device.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,597 Previous Clinical Trials
918,639 Total Patients Enrolled
David C Mohr, PhDPrincipal InvestigatorNorthwestern University
6 Previous Clinical Trials
699 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being enrolled in this clinical research study?

"Indeed, the details provided on clinicaltrials.gov indicate that this clinical investigation is actively seeking volunteers. Initial data was shared on December 4th, 2023 and updated lastly on April 18, 2024. Enrollment of around 160 participants will occur at a single designated location."

Answered by AI

Are participants currently being enrolled in this research study?

"Affirmative. The details outlined on clinicaltrials.gov indicate that this particular medical trial is presently enrolling participants. Initial posting of the trial occurred on December 4th, 2023, with its latest update recorded on April 18th, 2024. A total of 160 individuals are sought after for involvement at a singular site."

Answered by AI
~80 spots leftby Oct 2024